세계의 좌심이 폐쇄(LAAC) 디바이스 시장 : 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2024-2032년)

The Global Left Atrial Appendage Closure Devices Market was valued at USD 1.8 billion in 2023 and is projected to experience significant growth, with an estimated CAGR of 19.2% from 2024 to 2032. The rising incidence of atrial fibrillation (AF), supportive government policies, and continuous advancements in medical technology are key drivers contributing to this market expansion.

The market is primarily divided into two product categories: endocardial LAA devices and epicardial LAA devices. Among these, endocardial LAA devices accounted for the largest share, generating USD 1.6 billion in 2023. The growth in this segment is attributed to the increasing demand for devices that effectively minimize the risk of blood clots from the left atrial appendage entering the bloodstream. These devices are widely recognized for their ability to reduce the occurrence of thromboembolic events while maintaining a favorable risk profile for procedural complications. Additionally, endocardial LAA closure devices are seen as a reliable option in combination with atrial fibrillation ablation procedures.

In terms of end users, the market is segmented into hospitals, ambulatory surgical centers, and other healthcare facilities. The hospital segment dominated in 2023 and is expected to reach USD 6 billion by the end of the forecast period. Hospitals continue to lead the market due to the increasing use of advanced LAA closure devices that offer superior operability, which is likely to boost patient preference for these settings. The growing number of patients requiring treatment for AF, coupled with a rise in disease screening efforts and improved healthcare infrastructure, further supports the expansion of this segment. The prevalence of AF in both developed and emerging markets with improving healthcare systems is also expected to drive hospital-based market growth.

North America market for LAA closure devices generated USD 1.3 billion in revenue in 2023 and is projected to grow at a CAGR of 17.6% from 2024 to 2032. Factors such as the presence of leading manufacturers, rising demand for LAA closure products, and the growing number of AF cases are pivotal to this market's robust growth. Key industry players continue to drive innovation in the development and commercialization of new devices, further reinforcing the market's expansion. The increasing prevalence of atrial fibrillation and the subsequent rise in hospital admissions will continue to fuel the demand for LAA closure devices in the region.

The left atrial appendage closure device market is positioned for strong growth, driven by technological innovations, rising disease prevalence, and increasing adoption of these devices in various healthcare settings.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of atrial fibrillation
    • 3.2.1.2 Strong product pipeline
    • 3.2.1.3 Increasing government initiatives
    • 3.2.1.4 Technological advancements in left atrial appendage closure devices
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Presence of alternate technologies
    • 3.2.2.2 High cost of LAA closure devices
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Reimbursement scenario
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn & Units)

• 5.1 Key trends
• 5.2 Endocardial LAA devices
• 5.3 Epicardial LAA devices

Chapter 6 Market Estimates and Forecast, By Procedure, 2021 - 2032 ($ Mn & Units)

• 6.1 Key trends
• 6.2 Percutaneous
• 6.3 Surgical

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn and Units)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn and Units)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 AtriCure
• 9.3 Boston Scientific Corporation
• 9.4 Lepu Medical Technology
• 9.5 LifeTech Scientific
• 9.6 MicroPort Scientific Corporation
• 9.7 Nanjing YDB Technology
• 9.8 Shanghai Push Medical Device Technology